Jasper Therapeutics
JSPR
JSPR
41 hedge funds and large institutions have $91.4M invested in Jasper Therapeutics in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 40 → 41 (+1)
1.34% less ownership
Funds ownership: 8.26% → 6.92% (-1.3%)
Holders
41
Holding in Top 10
3
Calls
$2.96M
Puts
–
Top Buyers
| 1 | +$4.06M | |
| 2 | +$3.14M | |
| 3 | +$2.07M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$1.24M |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$623K |
Top Sellers
| 1 | -$39.2M | |
| 2 | -$6.93M | |
| 3 | -$3.15M | |
| 4 |
ACM
Altium Capital Management
New York
|
-$2.01M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1,000K |